J&J bags option on AdoRx lung cancer drugs - FierceBiotech
J&J bags option on AdoRx lung cancer drugs FierceBiotech
Johnson & Johnson Is teaming up with AdoRx Therapeutics to develop lung cancer drugs. The deal gives J&J an exclusive option to research, develop and ...
Comments
Post a Comment